ALPROSTADIL 25MCG/ML 25MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
Vita Pharmacy, LLC
Class I - Dangerous
Lack of assurance of sterility
💊
Prescription Drugs
💊 Drugs • 12,141 recalls
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 2/PGE-1 30 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
Vita Pharmacy, LLC
Class I - Dangerous
Lack of assurance of sterility
Irbesartan and Hydrochlorothiazide Tablets USP, 300/12.5 mg a) 30 count (NDC 68180-414-06) and b) 90 count (NDC 68180-414-09) bottles, Rx only
Lupin Pharmaceuticals
Class I - Dangerous
CGMP Deviations: impurity N-nitrosoirbesartan detected in API
Irbesartan Tablets USP, 150 mg a) 30 count (NDC 68180-411-06) and b) 90 count (NDC 68180-411-09) bottles, Rx only
Lupin Pharmaceuticals
Class I - Dangerous
CGMP Deviations: impurity N-nitrosoirbesartan detected in API
Irbesartan Tablets USP, 300 mg a) 30 count (NDC 68180-412-06) and b) 90 count NDC# 68180-412-09) bottles, Rx only
Lupin Pharmaceuticals
Class I - Dangerous
CGMP Deviations: impurity N-nitrosoirbesartan detected in API
Class I - Dangerous
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Class I - Dangerous
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Irbesartan Tablets USP, 75 mg a) 30 count (NDC 68180-410-06) and b) 90 count (NDC 68180-410-09) bottles, Rx only
Lupin Pharmaceuticals
Class I - Dangerous
CGMP Deviations: impurity N-nitrosoirbesartan detected in API
Class I - Dangerous
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Class I - Dangerous
Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle
Class I - Dangerous
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Class I - Dangerous
Presence of Particulate Matter: Identified as Glass Particles
Methocarbamol 500mg Tablet, packaged in a) #30 count (NDC 7133517952), b) #60 count (NDC 7133517954), and c) #90 count (NDC 7133517957) bottles, Rx only, Prinston Laboratories, Packaged by Bryant Ranch Prepack Burbank, CA 91504
Bryant Ranch Prepack, Inc.
Class I - Dangerous
Labeling: Label Error on Declared Strength; Bottles labeled as Methocarbamol 500 mg Tablets actually contain Methocarbamol 750 mg Tablets
Irbesartan and Hydrochlorothiazide Tablets USP, 150/12.5 mg a) 30 count (NDC 68180-413-06) and b) 90 count (NDC 68180-413-09) bottles, Rx only
Lupin Pharmaceuticals
Class I - Dangerous
CGMP Deviations: impurity N-nitrosoirbesartan detected in API
Class I - Dangerous
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
PYRIDOXINE HCL (B6) 100MG/ML MDV, Red Mountain Compounding Rx
First Royal Care Co. LLC
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class I - Dangerous
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.
METHYLCOBALAMIN 10,000MCG/ML MDV INJ, Rx only, Red Mountain Compounding Rx
First Royal Care Co. LLC
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
TEST CYP 50MG/ML IN ETHYL OLEATE OIL, Rx only, Red Mountain Compounding Rx
First Royal Care Co. LLC
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns